Drug
Cvncov 6 G
Cvncov 6 G: highest development phase Phase 2, developed by CureVac. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CVnCoV 6 μg NCT04515147 | Phase 2 | Coronavirus |
Latest
No recent events.
Follow Cvncov 6 G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.